Pancreatic Adenocarcinoma | Norton Healthcare

Indication: Pancreatic Adenocarcinoma

A Phase II Study of Preoperative Gemcitabine and Erlotinib Plus Pancreatectomy and Postoperative Gemcitabine and Erlotinib for Patients with Operable Pancreatic Adenocarcinoma

Sub-indication: Pancreatic Adenocarcinoma

Drug Study - IND

Principal Investigator: Robert Martin, M.D., Ph.D.
University of Louisville Physicians - Surgical Oncology

Sponsor: ACOSOG

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.